What Makes a Medtech Company Investable? Interview with Neuros Medical CEO David Veino

episode

Scott Nelson Live not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Scott Nelson Live

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec 57 min · 16 Dec 2025

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD 52 min · 10 Dec 2025

All episodes from Scott Nelson Live →

Report any issue

Source

Recorded04 Aug 2026

Publisherfeeds.transistor.fm ↗

Handlerec:20244350

Show notes

In this episode, we sat down with David Veino ( https://www.linkedin.com/in/david-veino-a452158/ ), President and CEO of Neuros Medical ( https://www.neurosmedical.com/ ). Neuros is commercializing the FDA-approved Altius Direct Electrical Nerve Stimul...

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.